Sentence examples for burden status from inspiring English sources

There is an enrichment for heterogeneously immune infiltrated tumours to have heterogeneous tumour mutational burden status and heterogeneous TIDE scores (Fisher's exact test).

f, A summary of the tumour histology, immune classification, tumour mutational burden status, TIDE category and IPRES category is shown for each tumour (n = 93).

In spite of her medical illness burden (status postnephrectomy, stage 3 renal failure, nephrogenic diabetes insipidus, status posthyperparathyroid resection with persistent hypercalcemia, history of subclinical hypothyroidism, and hyperthyroidism), lithium continued to be her maintenance mood stabilizer.

These factors, which may well have affected the epidemiology of cervical cancer, taken together with the recent incorporation of HPV vaccination strategies render it necessary for the pertinent tumour burden status to be updated in Spain, so as to be able to assess the future impact of preventive measures.

The support group's effects were measured using changes in the subjects' perceived levels of burden, depression status and satisfaction about their participation in the program.

This could result in an underestimation of the burden, health status and well-being of this population.

In particular we were interested in examining if IR was related to inflammatory disease burden, serological status or early therapy exposure.

Our analysis was limited by not accounting for other baseline prognostic factors; thus, there may be confounding factors (e.g., overall disease burden, performance status) leading to bias.

For each NHG guideline key recommendations have been selected based on relevance of disease burden, revision status of the guideline, and opportunity to translate or normalise the recommendation into if-then rules.

Gender, age at interview and the clinical features that were significantly different between the two groups (P<0.05) in the univariate analyses were entered as cofactors to establish which clinical features best predicted medical illness burden group status.

While survival is generally a preferred endpoint in oncology clinical trials, survival endpoints may not be appropriate for a biosimilar comparability trial as they can be influenced by confounding factors such as tumor burden, disease status, and previous lines of therapy.